During the past decade, Southern California Desert Retina Consultants conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 16 clinical trials were completed, i.e. on average, 94.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 11 clinical trials were completed. i.e. 220% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern California Desert Retina Consultants" #1 sponsor was "Jaeb Center for Health Research" with 14 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Southern California Desert Retina Consultants, MC" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern California Desert Retina Consultants" #1 collaborator was "National Eye Institute (NEI)" with 15 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 4 trials as a collaborator, "Regeneron Pharmaceuticals" with 4 trials as a collaborator and "Allergan" with 3 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Southern California Desert Retina Consultants" are "Diabetic Macular Edema" (12 trials), "Diabetic Retinopathy" (6 trials), "Geographic Atrophy" (4 trials), "Proliferative Diabetic Retinopathy" (3 trials) and "Age-related Macular Degeneration" (2 trials). Many other conditions were trialed in "Southern California Desert Retina Consultants" in a lesser frequency.

Most popular intervention types in "Southern California Desert Retina Consultants" are "Drug" (29 trials), "Procedure" (8 trials), "Other" (7 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ranibizumab" (6 trials), "Faricimab" (5 trials), "Sham Procedure" (5 trials), "Aflibercept" (4 trials) and "Deferred aflibercept" (2 trials). Other intervention names were less common.

The vast majority of trials in "Southern California Desert Retina Consultants" are 34 trials for "All" genders.

Currently, there are NaN active trials in "Southern California Desert Retina Consultants". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Southern California Desert Retina Consultants, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Southern California Desert Retina Consultants, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".